Posts Tagged: Dr. Kristina Lybecker


Trans-Pacific Partnership – What do IP practitioners need to know?

Trade partners negotiating the Tans-Pacific Partnership trade deal have reached an agreement. The agreement details have not been released, and likely will not be submitted to Congress …
By Gene Quinn
5 years ago 4

Protecting Data Exclusivity, Protecting the Future of Medicine

Traditionally, “small molecule” drugs are patent protected for a twenty-year term. Biologic medicines, however, are more difficult to comprehensively protect with patents due to their size, complexity, …

The Importance of Protecting Incremental, Improvement Innovation

Innovation provides new therapies and breakthrough treatments that extend and enhance life. The scientific and financial resources required for these advances are an investment worth making and …

Are Pharmaceutical Patents A Barrier to Access to Medicines? The Importance Economic Development and Growth

Critics argue that pharmaceutical patents are a barrier to wide-reaching access to medicines, especially for vulnerable populations in the developing world. They cast their argument in the …

Economics of Access to Medicines: The Challenges of Pharmaceutical Patents, Innovation and Access for Global Health

While it is easy to point to patents and blame the industry and international trade agreements for barriers to access to medicines in developing nations, the reality …